Intuitive Surgical (NASDAQ:ISRG) VP Fredrik Widman Sells 133 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Fredrik Widman sold 133 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the transaction, the vice president owned 660 shares of the company’s stock, valued at $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Intuitive Surgical Stock Up 0.2%

NASDAQ:ISRG traded up $0.97 during trading hours on Wednesday, hitting $496.12. 1,932,802 shares of the company’s stock traded hands, compared to its average volume of 2,229,982. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08. The business’s fifty day simple moving average is $546.68 and its two-hundred day simple moving average is $510.62. The firm has a market cap of $176.19 billion, a P/E ratio of 62.88, a P/E/G ratio of 3.83 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter last year, the company posted $2.21 EPS. The company’s revenue for the quarter was up 18.8% on a year-over-year basis. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ISRG. Royal Bank Of Canada boosted their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 17th. Daiwa Securities Group lifted their price target on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. UBS Group reaffirmed a “neutral” rating on shares of Intuitive Surgical in a report on Thursday, January 15th. Finally, Sanford C. Bernstein boosted their price target on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $617.23.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds have recently made changes to their positions in the business. Norges Bank bought a new stake in Intuitive Surgical during the 4th quarter valued at approximately $2,856,987,000. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Intuitive Surgical by 1,043.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after purchasing an additional 1,224,734 shares during the period. Rakuten Investment Management Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at approximately $388,436,000. Assenagon Asset Management S.A. boosted its position in shares of Intuitive Surgical by 106.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after purchasing an additional 791,516 shares in the last quarter. Finally, Amundi grew its stake in Intuitive Surgical by 29.7% in the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock worth $1,451,362,000 after purchasing an additional 739,444 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.